Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease
Open Access
- 1 February 2011
- journal article
- research article
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. 6, 157-69
- https://doi.org/10.2147/COPD.S16070
Abstract
Peer reviewed article authored by (Alicia Lacoma, Cristina Prat, Felipe Andreo, et al). Read article or submit your manuscript for publishing.Keywords
This publication has 38 references indexed in Scilit:
- Effect of Procalcitonin-Guided Treatment in Patients with Infections: a Systematic Review and Meta-AnalysisInfection, 2009
- Exacerbation rate, health status and mortality in COPD – a review of potential interventionsInternational Journal of Chronic Obstructive Pulmonary Disease, 2009
- Change in inflammation in out-patient COPD patients from stable phase to a subsequent exacerbationInternational Journal of Chronic Obstructive Pulmonary Disease, 2009
- The influence of corticosteroids on the release of novel biomarkers in human endotoxemiaIntensive Care Medicine, 2007
- Value of serum procalcitonin, neopterin, and C-reactive protein in differentiating bacterial from viral etiologies in patients presenting with lower respiratory tract infectionsDiagnostic Microbiology and Infectious Disease, 2007
- Systemic Effects of SmokingChest, 2007
- Antibiotic Treatment of Exacerbations of COPDChest, 2007
- Mortality in COPD: role of comorbiditiesEuropean Respiratory Journal, 2006
- C-reactive protein — can it be used as a marker of infection in patients with exacerbation of chronic obstructive pulmonary disease?European Journal of Internal Medicine, 2006
- Practice Guidelines for the Management of Community-Acquired Pneumonia in AdultsClinical Infectious Diseases, 2000